Schering-Plough Posaconazole NDA User Fee Date Is March 2005

Potential spring launch of invasive fungal infection agent Noxafil could be Schering’s next new product after Vytorin; the Zetia/Zocor combination’s user fee date is July 24. Schering’s remaining NME in Phase III is another anti-infective.